Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical ImagingROCO:6637 +0.16%86 Return-on-Tangible-Asset is 5.77% as of Mar. 2026, which is 60% below its 10-year median of 14.33. GuruFocus rates ROCO:6637 with a GF Score™ of 86/100 and a GF Value™ of NT$130.31 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 120 Medical Distribution companies, Medical Imaging ranks better than 91.67% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Medical Imaging's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$108 Mil. Medical Imaging's average total tangible assets for the quarter that ended in Mar. 2026 was NT$1,879 Mil. Therefore, Medical Imaging's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 5.77%.
The historical rank and industry rank for Medical Imaging's Return-on-Tangible-Asset or its related term are showing as below:
ROCO:6637'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 9.38 Med: 14.33 Max: 16.46
Current: 10.35
During the past 13 years, Medical Imaging's highest Return-on-Tangible-Asset was 16.46%. The lowest was 9.38%. And the median was 14.33%.
ROCO:6637's Return-on-Tangible-Asset is ranked better than 91.67% of 120
companies
in the Medical Distribution industry
Industry Median: 2.43
vs ROCO:6637: 10.35
Medical Imaging (ROCO:6637) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Medical Imaging Return-on-Tangible-Asset Related Terms
Medical Imaging Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Medical Imaging's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6637 vs MCK, COR, CAH: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Medical Imaging's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Imaging Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medical Imaging's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Medical Imaging's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 5.77% mean?
Medical Imaging (ROCO:6637) has a Return-on-Tangible-Asset of 5.77% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medical Imaging and its competitors. This is 60% below median its historical median of 14.33. Over the past decade, Medical Imaging's Return-on-Tangible-Asset has ranged from 9.38 to 16.46. According to the industry distribution chart, Medical Imaging ranks #10 out of 120 companies in the Medical Distribution industry, placing it in the top 8.3%.
Is Medical Imaging's Return-on-Tangible-Asset too high?
Medical Imaging's current Return-on-Tangible-Asset of 5.77% is 60% below median its 10-year median of 14.33. Over the past 10 years, this metric has ranged from a low of 9.38 to a high of 16.46. The Medical Distribution industry median Return-on-Tangible-Asset is 2.43. Medical Imaging's value of 5.77% is 137.4% above this industry median. Based on the distribution chart, Medical Imaging ranks #10 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medical Imaging has a GF Score™ of 86/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medical Imaging's Return-on-Tangible-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medical Imaging ranks #10 out of 120 companies for Return-on-Tangible-Asset. This places Medical Imaging in the top 8% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.43. Medical Imaging's value of 5.77% is 137.4% above this benchmark. Historically, Medical Imaging's own Return-on-Tangible-Asset has ranged from 9.38 to 16.46 over the past decade. While the company's 10-year median is 14.33 vs. the industry median of 2.43, Medical Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.43, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Imaging's current Return-on-Tangible-Asset of 5.77% is 137.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medical Imaging and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Imaging's current Return-on-Tangible-Asset is 5.77%, which is 60% below median its own 10-year median of 14.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Imaging stock overvalued right now?
Based on GuruFocus' analysis, Medical Imaging (ROCO:6637) is currently considered Possible Value Trap. The stock's GF Value™ is NT$130.31, compared to a current price of NT$61.90 — trading 52.5% below its estimated fair value. The current Return-on-Tangible-Asset is 5.77%, which is 60% below median its 10-year median of 14.33 and 137.4% above the Medical Distribution industry median of 2.43. Medical Imaging's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Medical Imaging (ROCO:6637), the current Return-on-Tangible-Asset is 5.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Imaging (ROCO:6637) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Imaging stock appears to be undervalued.
The current stock price of NT$61.90 is trading 52.5% below its estimated GF Value™ of NT$130.31.
GuruFocus considers Medical Imaging to be Possible Value Trap.
Key valuation signals for ROCO:6637:
Return-on-Tangible-Asset: 5.77% (60% below median its 10-year median of 14.33)
GF Value™: NT$130.31 vs. price of NT$61.90 (52.5% below fair value)
Industry Position: 137.4% above the Medical Distribution median (#10 of 120)
No single metric tells the full story. See the ROCO:6637 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Imaging Corp is a Taiwan based medical equipment company. It is engaged in medical equipment distribution, hospital equipment rental, and equipment maintenance.
86GF Score
Get the complete analysis for ROCO:6637
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6637 has been successfully added to your 
